Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess.
We are developing novel therapies to address the key limitations of treatments for endogenous Cushing’s syndrome (Cushing’s), autonomous cortisol secretion (ACS), and polymyalgia rheumatica (PMR).
Backed by world-class investors, we are prepared to take our medical p...
Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess.
We are developing novel therapies to address the key limitations of treatments for endogenous Cushing’s syndrome (Cushing’s), autonomous cortisol secretion (ACS), and polymyalgia rheumatica (PMR).
Backed by world-class investors, we are prepared to take our medical products through the entire development continuum – from clinical trials to regulatory approval, to commercialization.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.